- Home
- INDO vs DXR Comparison
INDO vs DXR Comparison
Compare INDO & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- DXR
- Stock Information
- Founded
- INDO 2018
- DXR 1970
- Country
- INDO Indonesia
- DXR United States
- Employees
- INDO N/A
- DXR N/A
- Industry
- INDO Oil & Gas Production
- DXR Medical/Dental Instruments
- Sector
- INDO Energy
- DXR Health Care
- Exchange
- INDO Nasdaq
- DXR Nasdaq
- Market Cap
- INDO 45.6M
- DXR 46.9M
- IPO Year
- INDO 2019
- DXR N/A
- Fundamental
- Price
- INDO $3.08
- DXR N/A
- Analyst Decision
- INDO
- DXR Strong Buy
- Analyst Count
- INDO 0
- DXR 1
- Target Price
- INDO N/A
- DXR $25.00
- AVG Volume (30 Days)
- INDO 412.2K
- DXR 6.5K
- Earning Date
- INDO 10-24-2025
- DXR 01-01-0001
- Dividend Yield
- INDO N/A
- DXR N/A
- EPS Growth
- INDO N/A
- DXR 3.46
- EPS
- INDO N/A
- DXR 0.36
- Revenue
- INDO $2,293,625.00
- DXR $66,306.00
- Revenue This Year
- INDO N/A
- DXR N/A
- Revenue Next Year
- INDO N/A
- DXR N/A
- P/E Ratio
- INDO N/A
- DXR $37.29
- Revenue Growth
- INDO N/A
- DXR N/A
- 52 Week Low
- INDO $2.10
- DXR $6.55
- 52 Week High
- INDO $7.95
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- INDO 52.38
- DXR 66.65
- Support Level
- INDO $2.94
- DXR $13.39
- Resistance Level
- INDO $3.06
- DXR $14.00
- Average True Range (ATR)
- INDO 0.13
- DXR 0.52
- MACD
- INDO 0.00
- DXR 0.13
- Stochastic Oscillator
- INDO 35.85
- DXR 80.93
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.